1.Management of Poor-grade Patients with Ruptured Intracranial Aneurysm.
Hyeon Seon PARK ; Yong Sam SHIN ; Seung Gon HUH ; Kyu Chang LEE
Journal of Korean Neurosurgical Society 1997;26(2):215-222
To formulate treatment strategies for poor-grade patients after aneurysmal subarachnoid hemorrhage(SAH), medical records were analyzed for 166 patients who were in Hunt and Hess grade IV or V among 588 consecutive aneurysmal SAH patients admitted during the past 5 years. Causes for unfavorable outcome(poor or dead) in these 166 patients were carefully evaluated to improve the management outcome. Overall management results were favorable(good or fair) in 71(42.8%), and unfavorable in 95(78 dead, 17 poor). Direct clipping was performed in 90 patients, and the surgical results were favorable in 69(76.7%) and unfavorable in 21(23.3%). Surgery was not performed in 76 patients because of moribund state on arrival in 41, neurological deterioration due to rebleeding in 15, massive brain swelling in seven, serious medical illness in five, severe delayed ischemic deficit in one, and massive cerebral infarction following angiography in one, and refused surgery in six. Seven patients survived from non-surgery group(2 fair, 5 poor). Direct effects of aneurysm rupture(34.8%) and early rebleeding(34.8%) were the causes of unfavorable outcome in grade IV patients, while it was direct effect of aneurysm rupture(91.8%) in grade V patients. It is suggested that since rebleeding is the only preventable factor of unfavorable outcome, urgent management seems necessary to prevent rebleeding, especially for grade IV patients. Grade IV patients should be treated aggressively with direct clipping for non-complex aneurysms or for patients with hematoma, and with coil embolization for complex aneurysms without hematoma.
Aneurysm
;
Angiography
;
Brain Edema
;
Cerebral Infarction
;
Embolization, Therapeutic
;
Hematoma
;
Humans
;
Intracranial Aneurysm*
;
Medical Records
2.Limb - Conserving Surgery and Interstitial Brachytherapy Plus External Radiation Therapy in Extremity Soft Tissue Sarcoma.
Yong Chan AHN ; Do Hoon LIM ; Jai Gon SEO ; Moon Kyung KIM ; Hong Gyun WU ; Dae Young KIM ; Seung Jae HUH
Journal of the Korean Cancer Association 1998;30(3):599-607
PURPOSE: In order to avoid functional disability that may be caused by radical excision or amputation in extremity soft tissue sarcomas, authors employed limb-conserving surgery together with extemal radiation therapy plus interstitial brachytherapy. MATERIALS AND METHODS: From June 1995 to Febrary 1997, 10 extremity soft tissue sarcoma patients were treated with limb-conserving surgery and external radiation therapy plus interstitial brachytherapy. In six patients, whose histologic diagnoses were made at the time of surgery, wide or marginal excision and interstitial brachytherapy was done 4 weeks before postoperative external radiation therapy. In four patients whose histologic confinnations were done before definitive treatment, preoperative external radiation therapy was given 4 weeks before surgery and interstitial brachytherapy. The types of surgery were wide excision in five patients, and marginal excision in five patients. Gross or microscopic residual was left at the surgical resection margins in four patients. The brachytherapy dose ranged from 17.5 Gy to 24 Gy and external beam radiation did from 40 Gy to 45 Gy. RESULTS: With the median follow-up duration of 21.5 months(range: 13 to 29 months); one local recurrence, and three new distant metastases were observed. There were three patients with wound complications attributable to the current treatment regimen. CONCLUSION: Satisfactory local tumor control may be achievable with limb-conserving surgery and external radiation therapy plus brachytherapy in patients with extremity soft tissue sarcomas, while more caution should be used to avoid wound problems.
Amputation
;
Brachytherapy*
;
Diagnosis
;
Extremities*
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Recurrence
;
Sarcoma*
;
Wounds and Injuries
3.A Case of Huge Left Ventricular Thrombus Associated with Hypereosinophilic Syndrome.
Jun Ho LEE ; Yun Nyun KIM ; Seung Ho HUH ; Sang Gon LEE ; Jeong Suk HEO ; Mi Sook KANG ; Kee Sik KIM ; Kwon Bae KIM
Korean Circulation Journal 1994;24(3):516-522
Cardiac manifestations of hypereosinophilic syndrome rarely include left ventricular thrombosis leading to peripheral emboli. And the cases of thrombectomy in patients with left ventricular thrombus and hypereosinophilic syndrome are extremely rare. Recently we experienced a 58-years-old woman with hypereosinophilic syndrome, the history of thalamic infarction and a huge thrombi in left ventricle. We report this case with literatures.
Female
;
Heart Ventricles
;
Humans
;
Hypereosinophilic Syndrome*
;
Infarction
;
Thrombectomy
;
Thrombosis*
4.Management of Intracranial Cavernous Malformation: A Retrospective Analysis of 76 Consecutive Cases.
Tae Gon KIM ; Seung Kon HUH ; Kyu Chang LEE ; Se Hyuk KIM ; Dong Suk KIM ; Yong Guo PARK ; Joong Uhn CHOI ; Sang Sub CHUNG
Journal of Korean Neurosurgical Society 2002;31(2):145-151
OBJECTIVE: To establish a treatment guideline for intracranial cavernous malformation, the authors analyzed the clinical features, treatment modality, complications, and late outcomes in 76 consecutive cases (45 microsurgical resections, 30 stereotactic radiosurgeries, one microsurgery followed by radiosurgery) managed at the Yonsei University Medical Center from 1985 to 1998. RESULTS: Among 104 lesions in 76 patients, 64(61.5%) lesions were supratentorial and 40(38.5%) infratentorial. Hemorrhage was the most common presentation(31 patients, 40.8%), followed by generalized seizure(15 patients, 19.7%). Fifteen(19.7%) patients had mixed presentation with generalized seizure and hemorrhage, while 9(11.9%) patients presented focal deficits. The remaining 6(7.9%) patients had headache or incidental lesion. Almost all infratentorial lesions(92.5%) were managed with radiosurgery, and 65.6% of supratentorial lesions with microsurgery. The average follow-up period was 14.6 months for the microsurgery group and 32 months for the radiosurgery group. The overall outcome was good in 68(89.5%), fair in 6(7.9%), poor in 1(1.3%), and dead in 1(1.3%). Total microsurgical resection and symptomatic cure rate was 95.6%. Two lesion were incompletely resected. One lesion was followed by radiosurgery and the other was followed by reoperation. Only 38.5% of lesions with radiosurgery were shrunken. CONCLUSION: Microsurgical removal is effective for lesions in the non-eloquent area, or with recurrent hemorrhages and seizures. Although radiosurgery could be considered for lesions with multiplicity in the eloquent or deep-seated area, further study for the radiosurgical effect on cavernous malformations is required.
Academic Medical Centers
;
Follow-Up Studies
;
Headache
;
Hemorrhage
;
Humans
;
Intracranial Hemorrhages
;
Microsurgery
;
Radiosurgery
;
Reoperation
;
Retrospective Studies*
;
Seizures
5.A Clinical Analysis of Delayed Radiation Necrosis of the Brain.
Jae Gon MOON ; Seung Kon HUH ; Joong Uhn CHOI ; Sang Sup CHUNG ; Kyu Chang LEE ; Dong Ik KIM ; Jung Ho SUH
Journal of Korean Neurosurgical Society 1989;18(6):926-930
Radiotherapy is a standard postoperative treatment for various cerebral neoplasms. Howewr, radiation has the potential to produce severe injury to normal brain tissue in and around the tumor bed. The authors encountered 7 patients with delayed cerebral necrosis. These unacceptable complication prompted us to analyze cases with such a complication particularly in regard to the differential diagnosis between the recurrence of the tumor and radiation necrosis of the brain. This article summarizes factors related to the radiation necrosis, including clinical observations and treatment.
Brain Injuries
;
Brain*
;
Diagnosis, Differential
;
Humans
;
Necrosis*
;
Radiotherapy
;
Recurrence
6.Long-term Results of Taking Anti-oxidant Nutritional Supplement in Intermediate Age-related Macular Degeneration
Seul Ki BANG ; Eung Suk KIM ; Jong Woo KIM ; Jae Pil SHIN ; Ji Eun LEE ; Hyeong Gon YU ; Kuhl HUH ; Seung Young YU
Journal of the Korean Ophthalmological Society 2018;59(12):1152-1159
PURPOSE: We prospectively investigated clinical changes and long-term outcomes after administration of the drugs recommended by the Age-Related Eye Disease Study-2 to patients with intermediate age-related macular degeneration (AMD). METHODS: This prospective multicenter study enrolled 79 eyes of 55 patients taking lutein and zeaxanthin. The primary endpoint was contrast sensitivity; this was checked every 12 months for a total of 36 months after treatment commenced. The secondary endpoints were visual acuity, central macular thickness, and drusen volume; the latter two parameters were assessed using spectral domain optical coherence tomography. RESULTS: The mean patient age was 72.46 ± 7.16 years. Contrast sensitivity gradually improved at both three and six cycles per degree. The corrected visual acuity was 0.13 ± 0.14 logMAR and did not change significantly over the 36 months. Neither the central macular thickness nor drusen volume changed significantly. CONCLUSIONS: Contrast sensitivity markedly improved after treatment, improving vision and patient satisfaction. Visual acuity, central retinal thickness, and drusen volume did not deteriorate. Therefore, progression of AMD and visual function deterioration were halted.
Contrast Sensitivity
;
Eye Diseases
;
Humans
;
Lutein
;
Macular Degeneration
;
Patient Satisfaction
;
Prospective Studies
;
Retinaldehyde
;
Tomography, Optical Coherence
;
Visual Acuity
;
Zeaxanthins
7.Clinical assessment and management of auricular arteriovenous malformation: retrospective study
Do Gon KIM ; Hyun Geun CHO ; Jeong Yeop RYU ; Joon Seok LEE ; Seok Jong LEE ; Jong Min LEE ; Sang Yub LEE ; Seung HUH ; Ji Yoon KIM ; Ho Yun CHUNG
Archives of Craniofacial Surgery 2021;22(3):141-147
Background:
Arteriovenous malformation (AVM) which is a high-blood-flow lesion with connections between arteries and veins without an intervening capillary bed, is difficult to manage. The ear is the second most common site of extracranial AVM. However, studies regarding the management of this condition remain lacking. The purpose of this study was to share managing experiences in our center and to investigate the treatment effect through a retrospective analysis of cases.
Methods:
Among 265 patients with AVM treated in our vascular anomalies center between January 2008 and January 2021, 10 patients with auricular AVM were included in the study to investigate the lesion distribution, clinical stage, and treatment methods by performing a retrospective evaluation.
Results:
Among 10 patients, five patients had AVMs distributed in the upper half of the ear, one patient in the lower half of the ear, and four patients in whole ear, respectively. Seven patients had Schobinger stage II, and three had stage III. One patient received surgical treatment only, four patients received sclerotherapy only, and five patients received both surgical treatment and sclerotherapy. The posttreatment status was checked as controlled in two patients, improved in seven patients, persistent in one patient. There were no worsening patients.
Conclusion
Auricular AVM is a disease that is difficult to manage by one specific department, thus requiring a collaborative management effort from multidisciplinary team.
8.Clinical assessment and management of auricular arteriovenous malformation: retrospective study
Do Gon KIM ; Hyun Geun CHO ; Jeong Yeop RYU ; Joon Seok LEE ; Seok Jong LEE ; Jong Min LEE ; Sang Yub LEE ; Seung HUH ; Ji Yoon KIM ; Ho Yun CHUNG
Archives of Craniofacial Surgery 2021;22(3):141-147
Background:
Arteriovenous malformation (AVM) which is a high-blood-flow lesion with connections between arteries and veins without an intervening capillary bed, is difficult to manage. The ear is the second most common site of extracranial AVM. However, studies regarding the management of this condition remain lacking. The purpose of this study was to share managing experiences in our center and to investigate the treatment effect through a retrospective analysis of cases.
Methods:
Among 265 patients with AVM treated in our vascular anomalies center between January 2008 and January 2021, 10 patients with auricular AVM were included in the study to investigate the lesion distribution, clinical stage, and treatment methods by performing a retrospective evaluation.
Results:
Among 10 patients, five patients had AVMs distributed in the upper half of the ear, one patient in the lower half of the ear, and four patients in whole ear, respectively. Seven patients had Schobinger stage II, and three had stage III. One patient received surgical treatment only, four patients received sclerotherapy only, and five patients received both surgical treatment and sclerotherapy. The posttreatment status was checked as controlled in two patients, improved in seven patients, persistent in one patient. There were no worsening patients.
Conclusion
Auricular AVM is a disease that is difficult to manage by one specific department, thus requiring a collaborative management effort from multidisciplinary team.
9.Photodynamic Therapy for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
Hyeong Gon YU ; Se Woong KANG ; Woo Ho NAM ; Hyoung Jun KOH ; Hyung Woo KWAK ; Oh Woong KWON ; Si Yeol KIM ; In Taek KIM ; Ha Kyoung KIM ; Hyun Woong KIM ; Young Jung ROH ; Jun Woong MOON ; Kyu Hyung PARK ; Suk Ho BYEON ; Su Jeong SONG ; Jae Kyoun AHN ; Boo Sup OUM ; Jae Ryung OH ; Seung Young YU ; Ill Han YOON ; Sung Chul LEE ; Won Ki LEE ; Jae Heung LEE ; Jeong Hee LEE ; Ji Eun LEE ; Tae Gon LEE ; Gwang Ju CHOI ; Don Il HAM ; Kuhl HUH ; Hum CHUNG
Journal of the Korean Ophthalmological Society 2007;48(6):789-798
PURPOSE: To investigate the effects of repeated photodynamic therapy (PDT) for subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD) in Korean patients. METHODS: Clinical data of patients who were treated with repeated (3 times or more) PDT for subfoveal choroidal neovascularization secondary to AMD and followed up for more than 6 months were collected from 17 hospitals around the country. Visual outcomes at 12 and 24 months, follow-up were compared between subtypes of choroidal neovascularization. The factors related to final visual prognosis and PDT-related adverse effects were evaluated. RESULTS: 244 patients (244 eyes) were recruited (male: 60%, age: 67.7+/-9.1 years). The portion of patients with predominantly classic, minimally classic, and occult without classic choroidal neovascularization was 57%, 13%, and 24%, respectively and that of patients with visual improvements or less than moderate visual loss at 24 months follow-up were 28%, 38%, 30% and 47%, 56%, and 65%, respectively. Baseline visual acuity and age were significantly related to the final visual prognosis (p<0.05). PDT-related adverse events developed in 15 (6.1%) patients, but most were mild and transient. CONCLUSIONS: Repeated PDT for subfoveal choroidal neovascularization secondary to AMD has effects comparable to those of previous prospective, controlled trials without any significant safety concerns in Korea.
Choroid*
;
Choroidal Neovascularization*
;
Follow-Up Studies
;
Humans
;
Korea
;
Macular Degeneration*
;
Photochemotherapy*
;
Prognosis
;
Visual Acuity